Engineered Variant Of Recombinant Human Fibroblast Growth Factor 19 Uses, Dosage, Side Effects and more
Engineered Variant Of Recombinant Human Fibroblast Growth Factor 19 is under investigation in clinical trial NCT03912532 (Evaluation of Efficacy, Safety and Tolerability of Engineered Variant Of Recombinant Human Fibroblast Growth Factor 19 in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study in Subjects With Nonalcoholic Steatohepatitis and Stage 2/3 Fibrosis (ALPINE 2/3)).
| Attribute | Details |
|---|---|
| Trade Name | Engineered Variant Of Recombinant Human Fibroblast Growth Factor 19 |
| Generic | Aldafermin |
| Aldafermin Other Names | (phe5>met,ser6>arg,ala8>ser,gly9>ser,his11>leu) fibroblast growth factor 19 (human fgf19) (5-194)-peptide, produced in escherichia coli, Aldafermin, Engineered variant of recombinant human fibroblast growth factor 19 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
